Evidence map›Paper›PMID 35882806›Full record

ArticleAdvances in experimental medicine and biology2022

Differences Between Physiological and Pharmacological Actions of Taurine.

Stephen W Schaffer, Chian Ju Jong, K C Ramila, Takashi Ito, Jay Kramer

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
20.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Metabolomics Insights into the Benefits of SGLT2 Inhibitors in Type 2 Diabetes.Clinical pharmacology : advances and applications · 2025
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Stephen W SchafferDepartment of Pharmacology, University of South Alabama College of Medicine, Mobile, AL, USA. sschaffe@southalabama.edu.
Chian Ju JongDepartment of Pharmacology, University of South Alabama College of Medicine, Mobile, AL, USA.
K C RamilaDepartment of Pharmacology, University of South Alabama College of Medicine, Mobile, AL, USA.
Takashi ItoFaculty of Bioscience and Biotechnology, Fukui Prefectural University, Fukui, Japan.
Jay KramerDepartment of Biochemistry and Molecular Medicine, The George Washington University, Washington, DC, USA.
University of South Alabama · USFukui Prefectural University · JPGeorge Washington University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In many experimental studies, pharmacological levels of taurine have been used to study physiological functions of taurine. However, this approach is unlikely to be fruitful, as pharmacological administration increases extracellular taurine, while physiological actions of taurine require alterations in intracellular taurine. Recognizing that different mechanisms might underlie the pharmacological and physiological actions of taurine, cardiac properties before and after exposure to various extracellular or intracellular concentrations of taurine were examined. To assess the effect of physiological taurine, myocardial contractility and metabolic status were compared in hearts containing different intracellular taurine concentrations. By contrast, the pharmacological actions of taurine were assessed in normal hearts perfused with buffer containing or lacking 10 mM taurine. Both pharmacological and physiological taurine increased contractile function and oxygen consumption. Yet, the pharmacological actions of taurine on contractile function were dependent on the L-type Ca

Indexed as

HeartTaurineAdenosine TriphosphateEnergy MetabolismMyocardiumAdenosine TriphosphateTaurineATP biosynthesisCa2+ transportFatty acid oxidationGlucose oxidationMitochondrial functionNADH/NAD+ ratioPPARαTaurine deficiency

Identifiers

PMID35882806
OpenAlexW4288075594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.